News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Urigen N.A. Completes Reverse Merger With Valentis, Inc. (VLTS)



7/16/2007 11:44:37 AM

BURLINGAME, Calif.--(BUSINESS WIRE)--Urigen N.A., Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders, has successfully completed its reverse merger into Valentis, Inc. on July 13, 2007. As a result, the Company plans to change its name to Urigen Pharmaceuticals, Inc. However, until such event unfolds, the Company will continue to trade on the Bulletin Board under the Valentis Inc. symbol (VLTS).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES